Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Sex differences in the pathogenesis of type 2 diabetes may explain the stronger impact of diabetes on atherosclerotic heart disease in women.

Mauvais-Jarvis F.

J Diabetes Complications. 2019 Jun;33(6):460-461. doi: 10.1016/j.jdiacomp.2019.03.006. Epub 2019 Apr 1. No abstract available.

PMID:
30981432
2.

Activation of hepatic estrogen receptor-α increases energy expenditure by stimulating the production of fibroblast growth factor 21 in female mice.

Allard C, Bonnet F, Xu B, Coons L, Albarado D, Hill C, Fagherazzi G, Korach KS, Levin ER, Lefante J, Morrison C, Mauvais-Jarvis F.

Mol Metab. 2019 Apr;22:62-70. doi: 10.1016/j.molmet.2019.02.002. Epub 2019 Feb 14.

3.

Sex Differences in Cardiovascular Risk Profile From Childhood to Midlife Between Individuals Who Did and Did Not Develop Diabetes at Follow-up: The Bogalusa Heart Study.

Du T, Fernandez C, Barshop R, Guo Y, Krousel-Wood M, Chen W, Qi L, Harville E, Mauvais-Jarvis F, Fonseca V, Bazzano L.

Diabetes Care. 2019 Apr;42(4):635-643. doi: 10.2337/dc18-2029. Epub 2019 Jan 28.

PMID:
30692238
4.

Emerging role of testosterone in pancreatic β-cell function and insulin secretion.

Xu W, Morford J, Mauvais-Jarvis F.

J Endocrinol. 2019 Jan 1. pii: JOE-18-0573.R1. doi: 10.1530/JOE-18-0573. [Epub ahead of print] Review.

PMID:
30601759
5.

GLP-1 Receptor in Pancreatic α-Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner.

Zhang Y, Parajuli KR, Fava GE, Gupta R, Xu W, Nguyen LU, Zakaria AF, Fonseca VA, Wang H, Mauvais-Jarvis F, Sloop KW, Wu H.

Diabetes. 2019 Jan;68(1):34-44. doi: 10.2337/db18-0317. Epub 2018 Nov 2.

PMID:
30389749
6.

Loss of Nuclear and Membrane Estrogen Receptor-α Differentially Impairs Insulin Secretion and Action in Male and Female Mice.

Allard C, Morford JJ, Xu B, Salwen B, Xu W, Desmoulins L, Zsombok A, Kim JK, Levin ER, Mauvais-Jarvis F.

Diabetes. 2019 Mar;68(3):490-501. doi: 10.2337/db18-0293. Epub 2018 Oct 10.

PMID:
30305367
7.

Bazedoxifene-induced vasodilation and inhibition of vasoconstriction is significantly greater than estradiol.

Zimmerman MA, Hutson DD, Mauvais-Jarvis F, Lindsey SH.

Menopause. 2019 Feb;26(2):172-181. doi: 10.1097/GME.0000000000001195.

PMID:
30130290
8.

An integrated view of sex differences in metabolic physiology and disease.

Clegg DJ, Mauvais-Jarvis F.

Mol Metab. 2018 Sep;15:1-2. doi: 10.1016/j.molmet.2018.06.011. Epub 2018 Jun 21. No abstract available.

9.

Estrogens Promote Misfolded Proinsulin Degradation to Protect Insulin Production and Delay Diabetes.

Xu B, Allard C, Alvarez-Mercado AI, Fuselier T, Kim JH, Coons LA, Hewitt SC, Urano F, Korach KS, Levin ER, Arvan P, Floyd ZE, Mauvais-Jarvis F.

Cell Rep. 2018 Jul 3;24(1):181-196. doi: 10.1016/j.celrep.2018.06.019.

10.

Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27).

Li J, Fu X, Cao S, Li J, Xing S, Li D, Dong Y, Cardin D, Park HW, Mauvais-Jarvis F, Zhang H.

J Biol Chem. 2018 Aug 17;293(33):12719-12729. doi: 10.1074/jbc.RA118.003075. Epub 2018 Jun 22.

PMID:
29934310
11.

Androgen excess in pancreatic β cells and neurons predisposes female mice to type 2 diabetes.

Navarro G, Allard C, Morford JJ, Xu W, Liu S, Molinas AJ, Butcher SM, Fine NH, Blandino-Rosano M, Sure VN, Yu S, Zhang R, Münzberg H, Jacobson DA, Katakam PV, Hodson DJ, Bernal-Mizrachi E, Zsombok A, Mauvais-Jarvis F.

JCI Insight. 2018 Jun 21;3(12). pii: 98607. doi: 10.1172/jci.insight.98607. eCollection 2018 Jun 21.

12.

Sex differences underlying pancreatic islet biology and its dysfunction.

Gannon M, Kulkarni RN, Tse HM, Mauvais-Jarvis F.

Mol Metab. 2018 Sep;15:82-91. doi: 10.1016/j.molmet.2018.05.017. Epub 2018 May 30. Review.

13.

Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion.

Gautier JF, Fetita LS, Riveline JP, Ibrahim F, Porcher R, Abi Khalil C, Velho G, Choukem SP, Hadjadj S, Larger E, Roussel R, Boudou P, Marre M, Ravussin E, Mauvais-Jarvis F.

J Endocr Soc. 2018 Mar 22;2(5):391-397. doi: 10.1210/js.2017-00482. eCollection 2018 May 1.

14.

Estrogen receptor α protects pancreatic β-cells from apoptosis by preserving mitochondrial function and suppressing endoplasmic reticulum stress.

Zhou Z, Ribas V, Rajbhandari P, Drew BG, Moore TM, Fluitt AH, Reddish BR, Whitney KA, Georgia S, Vergnes L, Reue K, Liesa M, Shirihai O, van der Bliek AM, Chi NW, Mahata SK, Tiano JP, Hewitt SC, Tontonoz P, Korach KS, Mauvais-Jarvis F, Hevener AL.

J Biol Chem. 2018 Mar 30;293(13):4735-4751. doi: 10.1074/jbc.M117.805069. Epub 2018 Jan 29.

15.

The Role of Estrogens in Pancreatic Islet Physiopathology.

Mauvais-Jarvis F, Le May C, Tiano JP, Liu S, Kilic-Berkmen G, Kim JH.

Adv Exp Med Biol. 2017;1043:385-399. doi: 10.1007/978-3-319-70178-3_18. Review.

PMID:
29224104
16.

Menopause, Estrogens, and Glucose Homeostasis in Women.

Mauvais-Jarvis F.

Adv Exp Med Biol. 2017;1043:217-225. doi: 10.1007/978-3-319-70178-3_11. Review.

PMID:
29224097
17.

Epidemiology of Gender Differences in Diabetes and Obesity.

Mauvais-Jarvis F.

Adv Exp Med Biol. 2017;1043:3-8. doi: 10.1007/978-3-319-70178-3_1. Review.

PMID:
29224087
18.

New Insights Into Estrogens Inactivation and Prevention of Systemic Inflammation in Male Subjects.

Mauvais-Jarvis F.

Endocrinology. 2017 Nov 1;158(11):3711-3712. doi: 10.1210/en.2017-00828. No abstract available.

19.

Are estrogens promoting immune modulation and islet protection in type 1 diabetes?

Mauvais-Jarvis F.

J Diabetes Complications. 2017 Nov;31(11):1563-1564. doi: 10.1016/j.jdiacomp.2017.07.015. Epub 2017 Aug 3. No abstract available.

PMID:
28890307
20.

The impact of androgen actions in neurons on metabolic health and disease.

Morford JJ, Wu S, Mauvais-Jarvis F.

Mol Cell Endocrinol. 2018 Apr 15;465:92-102. doi: 10.1016/j.mce.2017.09.001. Epub 2017 Sep 4. Review.

21.

Gender differences in glucose homeostasis and diabetes.

Mauvais-Jarvis F.

Physiol Behav. 2018 Apr 1;187:20-23. doi: 10.1016/j.physbeh.2017.08.016. Epub 2017 Aug 24. Review.

22.

Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase.

Dong S, Baranwal S, Garcia A, Serrano-Gomez SJ, Eastlack S, Iwakuma T, Mercante D, Mauvais-Jarvis F, Alahari SK.

J Biol Chem. 2017 Oct 13;292(41):16833-16846. doi: 10.1074/jbc.M117.784256. Epub 2017 Aug 24.

23.

Differential Effects of Linagliptin on the Function of Human Islets Isolated from Non-diabetic and Diabetic Donors.

Zhang Y, Wu M, Htun W, Dong EW, Mauvais-Jarvis F, Fonseca VA, Wu H.

Sci Rep. 2017 Aug 11;7(1):7964. doi: 10.1038/s41598-017-08271-9.

24.

A Guide for the Design of Pre-clinical Studies on Sex Differences in Metabolism.

Mauvais-Jarvis F, Arnold AP, Reue K.

Cell Metab. 2017 Jun 6;25(6):1216-1230. doi: 10.1016/j.cmet.2017.04.033. Review.

25.

KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.

Song J, Yang Y, Mauvais-Jarvis F, Wang YP, Niu T.

BMC Med Genet. 2017 Jun 6;18(1):64. doi: 10.1186/s12881-017-0422-7.

26.

Incretin-Based Therapies: Revisiting Their Mode of Action.

Layden BT, Wicksteed B, Mauvais-Jarvis F.

Endocrinology. 2017 Jun 1;158(6):1560-1563. doi: 10.1210/en.2017-00252. No abstract available.

27.

Perinatal Exposure to Western Diet Programs Autonomic Dysfunction in the Male Offspring.

Mukerjee S, Zhu Y, Zsombok A, Mauvais-Jarvis F, Zhao J, Lazartigues E.

Cell Mol Neurobiol. 2018 Jan;38(1):233-242. doi: 10.1007/s10571-017-0502-4. Epub 2017 May 6.

28.

Androgen receptor-deficient islet β-cells exhibit alteration in genetic markers of insulin secretion and inflammation. A transcriptome analysis in the male mouse.

Xu W, Niu T, Xu B, Navarro G, Schipma MJ, Mauvais-Jarvis F.

J Diabetes Complications. 2017 May;31(5):787-795. doi: 10.1016/j.jdiacomp.2017.03.002. Epub 2017 Mar 9.

29.

Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications.

Mauvais-Jarvis F, Manson JE, Stevenson JC, Fonseca VA.

Endocr Rev. 2017 Jun 1;38(3):173-188. doi: 10.1210/er.2016-1146. Review.

30.

Differential sex effects of systolic blood pressure and low-density lipoprotein cholesterol on type 2 diabetes: Life course data from the Bogalusa Heart Study.

Pollock BD, Chen W, Harville EW, Shu T, Fonseca V, Mauvais-Jarvis F, Kelly TN, Bazzano LA.

J Diabetes. 2018 Jun;10(6):449-457. doi: 10.1111/1753-0407.12543. Epub 2017 Apr 6.

31.

Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?

Mauvais-Jarvis F.

Diabetes. 2017 Mar;66(3):568-570. doi: 10.2337/dbi16-0063. No abstract available.

32.

Roles of G protein-coupled estrogen receptor GPER in metabolic regulation.

Sharma G, Mauvais-Jarvis F, Prossnitz ER.

J Steroid Biochem Mol Biol. 2018 Feb;176:31-37. doi: 10.1016/j.jsbmb.2017.02.012. Epub 2017 Feb 20. Review.

33.

The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.

Xu B, Lovre D, Mauvais-Jarvis F.

J Diabetes Complications. 2017 Apr;31(4):773-779. doi: 10.1016/j.jdiacomp.2016.12.010. Epub 2017 Jan 20. Review.

34.

Sex differences in the effects of androgens acting in the central nervous system on metabolism.

Morford J, Mauvais-Jarvis F.

Dialogues Clin Neurosci. 2016 Dec;18(4):415-424. Review.

35.

Developing Academic Visibility in the Medical Sciences.

Mauvais-Jarvis F.

Ochsner J. 2016 Fall;16(3):208-9. No abstract available.

36.

Role of Sex Steroids in β Cell Function, Growth, and Survival.

Mauvais-Jarvis F.

Trends Endocrinol Metab. 2016 Dec;27(12):844-855. doi: 10.1016/j.tem.2016.08.008. Epub 2016 Sep 15. Review.

37.

The D-Day of ghrelin.

Tong J, Mauvais-Jarvis F.

Mol Metab. 2016 May 20;5(7):433-434. doi: 10.1016/j.molmet.2016.05.007. eCollection 2016 Jul. No abstract available.

38.

Effect of menopausal hormone therapy on components of the metabolic syndrome.

Lovre D, Lindsey SH, Mauvais-Jarvis F.

Ther Adv Cardiovasc Dis. 2016 May 27. pii: 1753944716649358. [Epub ahead of print] Review.

39.

Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male.

Navarro G, Xu W, Jacobson DA, Wicksteed B, Allard C, Zhang G, De Gendt K, Kim SH, Wu H, Zhang H, Verhoeven G, Katzenellenbogen JA, Mauvais-Jarvis F.

Cell Metab. 2016 May 10;23(5):837-51. doi: 10.1016/j.cmet.2016.03.015. Epub 2016 Apr 28.

40.

Letter to the Editor: "Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man" by Hazlehurst J.M., Oprescu A.I., Nikolaou N., et al.

Mauvais-Jarvis F.

J Clin Endocrinol Metab. 2016 Apr;101(4):L46-7. doi: 10.1210/jc.2016-1150. No abstract available.

PMID:
27032326
41.

Androgen-deprivation therapy and pancreatic β-cell dysfunction in men.

Mauvais-Jarvis F.

J Diabetes Complications. 2016 Apr;30(3):389-90. doi: 10.1016/j.jdiacomp.2016.01.007. Epub 2016 Jan 11. No abstract available.

PMID:
26861947
42.

Letter to the Editor: "Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program" by Mather K.J., et al.

Mauvais-Jarvis F.

J Clin Endocrinol Metab. 2015 Dec;100(12):L126-7. doi: 10.1210/jc.2015-3755. No abstract available.

PMID:
26642271
43.

Liraglutide in Weight Management.

Mauvais-Jarvis F.

N Engl J Med. 2015 Oct 29;373(18):1779-80. doi: 10.1056/NEJMc1509759. No abstract available.

PMID:
26510030
44.

PAX4 Gene Transfer Induces α-to-β Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment.

Zhang Y, Fava GE, Wang H, Mauvais-Jarvis F, Fonseca VA, Wu H.

Mol Ther. 2016 Feb;24(2):251-260. doi: 10.1038/mt.2015.181. Epub 2015 Oct 5.

45.

Sex differences in metabolic homeostasis, diabetes, and obesity.

Mauvais-Jarvis F.

Biol Sex Differ. 2015 Sep 3;6:14. doi: 10.1186/s13293-015-0033-y. eCollection 2015. Review.

46.

Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetes.

Choukem SP, Sobngwi E, Garnier JP, Letellier S, Mauvais-Jarvis F, Calvo F, Gautier JF.

Diabetes Metab. 2015 Sep;41(4):326-30. doi: 10.1016/j.diabet.2014.07.002. Epub 2015 Sep 1.

PMID:
26337344
47.

Trends in Prevalence of the Metabolic Syndrome.

Lovre D, Mauvais-Jarvis F.

JAMA. 2015 Sep 1;314(9):950. doi: 10.1001/jama.2015.8625. No abstract available.

PMID:
26325567
48.

Effect of selective estrogen receptor modulators on metabolic homeostasis.

Xu B, Lovre D, Mauvais-Jarvis F.

Biochimie. 2016 May;124:92-97. doi: 10.1016/j.biochi.2015.06.018. Epub 2015 Jun 29. Review.

PMID:
26133657
49.

Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome.

Hevener AL, Clegg DJ, Mauvais-Jarvis F.

Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:306-21. doi: 10.1016/j.mce.2015.05.020. Epub 2015 May 29. Review.

50.

Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis.

Tiano JP, Tate CR, Yang BS, DiMarchi R, Mauvais-Jarvis F.

Sci Rep. 2015 May 13;5:10211. doi: 10.1038/srep10211.

Supplemental Content

Loading ...
Support Center